208-week outcomes of cipaglucosidase alfa plus miglustat in patients with late-onset Pompe disease treated from PROPEL baseline: Pulmonary function

Molecular Genetics and Metabolism 2026

View at publisher
Authors: Priya S. Kishnani, Drago Bratkovic, Kristl G. Claeys, Jordi Diaz-Manera, Tahseen Mozaffar, Mark E. Roberts, Benedikt Schoser, Antonio Toscano, Fred K. Holdbrook, Vipul Jain, Pilar Moore, Kinesha O'Brien-Prince
+1 more Michael Polkey
DOI: 10.1016/j.ymgme.2025.109503
Cited by: 1

Fields of Study & Subjects

Lysosomal Storage Disorders Research Glycogen Storage Diseases and Myoclonus Whipple's Disease and Interleukins

Publication details

Journal / source
Molecular Genetics and Metabolism
Publisher
Elsevier BV
Volume
147
Issue
2
Pages
109503–109503
Publication date
1 February 2026
Language
EN